|
J 24.2:Us 2
|
Time to focus on the user |
1 |
|
J 24.2:V 41
|
Vaping & marijuana concentrates : what is vaping? |
1 |
|
J 24.2:V 41/SPAN.
|
El cigarrillo electrónico y los concentrados de marihuana : ¿Qué es el "vapeo"? |
1 |
|
J 24.2:X 9
|
The growing threat of xylazine and its mixture with illicit drugs : DEA joint intelligence report |
1 |
|
J 24.29:
|
Drug trafficking in the United States |
1 |
|
J 24.30:
|
DEA update |
1 |
|
J 24.31:
|
Microgram bulletin |
1 |
|
J 24.31/2:
|
Microgram journal |
1 |
|
J 24.32:C 64
|
Colombian cocaine production expansion contributes to rise in supply in the United States |
1 |
|
J 24.32:F 36
|
Fentanyl remains the most significant synthetic opioid threat and poses the greatest threat to the opioid user market in the United States |
1 |
|
J 24.32:H 43
|
The 2015 heroin signature program report |
1 |
|
J 24.32:OP 3
|
The opioid threat in the Chicago Field Division |
1 |
|
J 24.34/2:
|
... Heroin Domestic Monitor Program |
1 |
|
J 24.34:003-21
|
Illicit opioid availability in Pennsylvania, 2020 |
1 |
|
J 24.34:004-21
|
Illicit stimulant availability in Pennsylvania, 2020 |
1 |
|
J 24.34:035-20
|
Counterfeit controlled prescription drug availability in Pennsylvania and Delaware |
1 |
|
J 24.34:C 31
|
Drug-caused deaths in the Los Angeles Field Division (2013-2017) |
1 |
|
J 24.34:D 37
|
The drug situation in Delaware |
1 |
|
J 24.34:F 36
|
Fentanyl flow to the United States |
1 |
|
J 24.34:M 33
|
Residential marijuana grows in Colorado : the new meth houses? |
1 |